Vanguard Group Inc Fibrogen Inc Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Fibrogen Inc stock. As of the latest transaction made, Vanguard Group Inc holds 5,859,125 shares of FGEN stock, worth $39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,859,125

Previous 5,876,976 0.3%

Holding current value

$39 Million

Previous $3.11 Million 41.68%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$0.31 - $0.77 $5,533 - $13,745	-17,851 Reduced 0.3%	5,859,125 $1.82 Million
Q4 2024 Feb 11, 2025	SELL	$0.3 - $0.58 $1,615 - $3,123	-5,385 Reduced 0.09%	5,876,976 $3.11 Million
Q3 2024 Nov 13, 2024	SELL	$0.33 - $1.26 $945 - $3,609	-2,865 Reduced 0.05%	5,882,361 $2.35 Million
Q2 2024 Aug 13, 2024	SELL	$0.89 - $2.36 $491,011 - $1.3 Million	-551,698 Reduced 8.57%	5,885,226 $5.24 Million
Q1 2024 May 10, 2024	SELL	$0.73 - $2.73 $443,274 - $1.66 Million	-607,225 Reduced 8.62%	6,436,924 $15.1 Million
Q4 2023 Feb 14, 2024	SELL	$0.38 - $0.91 $766,381 - $1.84 Million	-2,016,794 Reduced 22.26%	7,044,149 $6.27 Million
Q3 2023 Nov 14, 2023	SELL	$0.79 - $2.83 $536,418 - $1.92 Million	-679,011 Reduced 6.97%	9,060,943 $7.79 Million
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $2.26 Million - $18.7 Million	909,324 Added 10.3%	9,739,954 $26.3 Million
Q1 2023 May 15, 2023	SELL	$15.95 - $25.18 $9.78 Million - $15.4 Million	-613,439 Reduced 6.5%	8,830,630 $165 Million
Q4 2022 Feb 10, 2023	SELL	$13.27 - $17.73 $3.94 Million - $5.26 Million	-296,873 Reduced 3.05%	9,444,069 $151 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $787,455 - $1.01 Million	69,075 Added 0.71%	9,740,942 $127 Million
Q2 2022 Aug 12, 2022	BUY	$7.94 - $12.96 $2.56 Million - $4.17 Million	321,910 Added 3.44%	9,671,867 $102 Million
Q1 2022 May 13, 2022	BUY	$12.02 - $16.79 $3.77 Million - $5.27 Million	313,769 Added 3.47%	9,349,957 $112 Million
Q4 2021 Feb 14, 2022	BUY	$9.93 - $15.39 $7.01 Million - $10.9 Million	706,241 Added 8.48%	9,036,188 $127 Million
Q3 2021 Nov 12, 2021	BUY	$10.18 - $26.64 $4.44 Million - $11.6 Million	436,089 Added 5.52%	8,329,947 $85.1 Million
Q2 2021 Aug 13, 2021	BUY	$18.57 - $35.68 $147 Million - $282 Million	7,893,858 New	7,893,858 $210 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

34.6M

Call Options Held

461K

Put Options Held

102K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $623M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Fibrogen Inc Transaction History